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To assess the relation of exercise capacity to indexes of systolic and
diastolic function in hypertrophic cardiomyopathy, 81 patients
underwent two-dimensional echocardiography, technetium-99m
equilibrium radionuclide angiography acquired in list mode and
maximal, symptom-limited, treadmill exercise testing with mea-
surement of maximal oxygen consumption (V02 max). V02 max
for the group was 13.9 to 49.3 (mean 25.4) mllmin per kg.
Thirty-six patients (44%) achieved :570% of age-predicted V02
max. Patients with such a degree of limitation were more likely to
be in New York Heart Association functional class II or III (23 of
36 vs. 14 of 45; P =0.005); there was no such relation between
V02 and the incidence and magnitude of rest left ventricular
outflow tract pressure gradient>30 mm Hg (11 of 36 vs. 11 of 45;
P =NS and 58 ± 24 vs. 65 ± 19 mm Hg; p =NS).
In the 22 patients with a left ventricular outflow tract gradient,
the ratios of peak ejection to peak filling rate and of atrial
contribution to left atrial dimension were related to percent of the
age-predicted V02 max (r =0.49, P =0.02 and r =0.54, p <
0.02). These ratios reflect impaired left ventricular systolic per-
formance and atrial systolic failure, respectively. Stepwise dis-
Exercise limitation is common in hypertrophic cardiomyop-
athy, although the mechanism in any individual patient may
be difficult to define (1-4). Rapidly responding oxygen and
carbon dioxide gas analyzers permit the noninvasive deter-
mination of respiratory gas exchange during exercise and the
objective quantitation of functional limitation (5,6). We
performed exercise testing with respiratory gas analysis in
addition to two-dimensional echocardiography and equilib-
rium radionuclide angiography to examine the mechanisms
of exercise limitation in hypertrophic cardiomyopathy.
Methods
Patients. Eighty-one consecutive patients with hyper-
trophic cardiomyopathy whose exercise capacity was lim-
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criminant analysis revealed these two ratios to be the two strongest
predictors (p =0.0001) of patients with a left ventricular outflow
tract gradient whose V02 max was :570% of the age-predicted
value (sensitivity 90%, specificity 100%).
In 59 patients without a rest left ventricular outflow tract
gradient, peak filling rate and time to end-systole were weakly
related to the age-predicted V02 max (r =0.27, P< 0.05 and r =
-0.28, P< 0.05). Stepwise discriminant analysis revealed that in
those patients without a left ventricular outflow tract gradient
reduced peak filling rate and prolonged time to end-systole best
identified (p =0.004) patients whose V02 max was :570% of the
age-predicted value (sensitivity 76%, specificity 62%).
These findings indicate different mechanisms of exercise limi-
tation in hypertrophic cardiomyopathy. In patients with a left
ventricular outflow gradient at rest, the main determinants of
exercise limitation were impaired left ventricular and left atrial
systolic performance. In those without a gradient, however,
diastolic function was a more important factor in the limitation of
exercise performance.
(J Am Coli CardioI1992;19:507-12)
ited by dyspnea or fatigue, or both, were examined by both
exercise respiratory gas analysis and equilibrium radionu-
clide angiography; patients with atrial fibrillation or moder-
ate to severe mitral regurgitation and those whose exercise
capacity was limited by chest pain, symptoms related to
arrhythmia or exertional hypotension were excluded. The
study patients were 12 to 71 (mean 41) years of age; 44 were
male and 37 female. The diagnosis was based on the echo-
cardiographic demonstration of unexplained left ventricular
hypertrophy (7). All patients had maximal left ventricular
wall thickness ~15 mm in the absence of aortic valve
disease, systemic hypertension or any other cause of myo-
cardial hypertrophy. The left ventricular ejection fraction
was ~60% (60 to 99%; mean 77%).
Exercise testing and respiratory gas analysis. Maximal
symptom-limited treadmill exercise testing was performed
when the patient was not receiving cardioactive medications
with the use of a modified Bruce protocol with continuous
measurement of oxygen consumption (8,9). Respiratory gas
analysis was performed with a SensorMedics "Horizon"
metabolic measurement cart. Oxygen and carbon dioxide
levels were measured with use of a temperature-controlled
0735-1097/92/$5.00
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Figure 1. Calculation of peak rates of left ventricular (LV) ejection
and filling, time intervals and relative filling volumes from the
radionuclide time-activity curve. Peak ejection rate (PER) and peak
filling rate (PFR) were normalized to end-diastolic counts and
expressed as changes from end-diastolic volume/second. Time to
peak ejection rate (TPER) and time to end-systole (TES) were
defined as the intervals from the Rwave to the point of peak ejection
and to end-systole (minimum ofthe curve). Time to peak filling rate
(TPFR) and isovolumetric relaxation period (IVRP) were defined as
the intervals from end-systole to the point of peak filling and to the
end of the isovolumetric relaxation period. Relative filling volume
by peak filling rate (RFVI), relative filling volume during the rapid
filling period (RFV2) and atrial contribution (AC) were defined as
proportional filling volume at each point and were normalized to
end-diastolic counts; dV/dt = change in volume over time.
(7%) atrial contribution and relative filling volume during the
rapid filling period could not be measured because a maxi-
mum on the second derivative curve, corresponding to each
inflection point, could not be clearly identified.
Echocardiography. Echocardiographic studies were per-
formed with a Toshiba SSH-65A or a General Electric
Pass-C. Acomplete M-mode and two-dimensional study was
performed and recorded on videotape for subsequent anal-
ysis. Criteria for the echocardiographic assessment of sever-
ity and extent of left ventricular hypertrophy have been
described previously (20). In brief, maximal wall thickness
> 15 mm and 1) a ratio of wall thickness> 1.5 between the
anterior or posterior septum and the left ventricular poste-
rior wall defined asymmetric septal hypertrophy; 2) the same
ratio between at least two of four segmental wall thickness
measurements in the lower versus the upper left ventricle
defined apical hypertrophy; and 3) neither of these defined
concentric hypertrophy. The presence of a gradient to the
left ventricular outflow tract was assessed by conventional
- t
AC..
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r
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Women: max V02 (ml/kg per min) = 48 - (age x 0,37).
An appropriate formula for the five patients aged <18 years
was used to calculate maximal oxygen consumption (13).
Equilibrium radionuclide angiography. The radionuclide
examination was performed in 74 patients while they were
not receiving any cardiac medication and at least 5 half-lives
after the discontinuation of beta-adrenergic blockers, vera-
pamil or antiarrhythmic agents in 7 patients.
Left ventricular systolic and diastolic function was as-
sessed by R wave-gated equilibrium radionuclide angiogra-
phy acquired in list mode. All studies were performed with
the patients at rest in the supine position; cuff blood pressure
and heart rate were recorded after 10 to 15 min of rest before
each study. After labeling of red blood cells in vivo with use
of 15-mCi technetium-99m (14,15), images were acquired
with use of a large field of view rotating gamma camera
(General Electric Maxi 4ooT) and medium sensitivity parallel
hole collimator oriented in a 45° left anterior oblique projec-
tion with caudal tilt. Data were acquired from 600 to 900
consecutive cycles and stored on computer (A2, Medical
Data Systems) for subsequent analysis. An RR interval
histogram was constructed and complexes falling outside an
operator-selected range (± 10% from the mean RR interval)
were rejected. A background-corrected composite left ven-
tricular time-activity curve was then generated at a frame
rate of 10 to 25 ms/frame by combined forward and reverse
gating from the R wave (16).
A standard count-based method was used to calculate
left ventricular ejection fraction (17). Isovolumetric relax-
ation period and atrial contribution were measured automat-
ically by the identification of a maximum on the second
derivative curve after end-systole and peak filling rate,
respectively (18). The ratio of atrial contribution to left atrial
dimension was also calculated. Seven other indexes of
systolic and diastolic function were derived, as previously
described (19) (Fig. 1). When normalized for end-diastolic
volume, peak ejection rate and peak filling rate are directly
influenced by the magnitude ofthe ejection fraction (19). To
minimize this effect, we also calculated the ratio of peak
ejection rate to peak filling rate and of peak filling rate to
peak ejection rate. In five patients (6%), isovolumetric
relaxation period could not be measured and in six others
rapid polarographic sensor and a dual-beam infrared optical
sensor respectively linked to an on-board microprocessor
(10). Printouts of minute ventilation, oxygen consumption,
carbon dioxide production and respiratory quotient were
obtained at 15-s intervals during exercise. Before the study,
patients underwent sessions to accustom them to the tech-
niques of exercise and respiratory gas collection and had
demonstrated a :510% difference in maximal oxygen con-
sumption (V02 max) on at least two consecutive tests.
Age-predicted V02 max was calculated with use of the
following formulas (11,12):
Men: max V02 (ml/kg per min) = 60 - (age x 0.55).
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Table 1. Exercise Testing in Patients With Age-Predicted
V02 max ::;70% Versus >70%
*p = 0.002, tp = 0.01; % VOz max = percent of age-predicted maximal
oxygen consumption; slope of heart rate increase = (heart rate at peak
exercise - heart rate at rest)/exercise duration: VOz max = maximal oxygen
consumption.
M-mode echocardiography with a recording at 100-mm/s
paper speed to analyze the magnitude and duration of
systolic anterior motion of the mitral valve (21).
Statistical analysis. Results were expressed as mean val-
ues ± 1SD. A Student t test was used to compare the means
of continuous variables. Contingency tables were analyzed
using the chi-square test. Linear discriminant analysis with
stepwise variable selection and Wilks' lambda as the selec-
tion and optimization criteria were used to assess the poten-
tial to predict functional capacity. Correlation coefficients
between radionuclide indexes and percent of age-predicted
VOz max were also calculated. All analyses were performed
with use of the SPSS-PC+ computer program.
42 ± 17
7 ± 4
13 (29%)
9 (20%)
31 (69%)'
13 (29%)
1 (2%)
% V02 max >70
(n = 45)
40 ± 14
6 ± 5
15 (42%)
8 (22%)
13 (36%)
17 (47%)
6 (17%)
% VOz max 0:;70
(n = 36)
Age (yr)
Follow-up after Dx (yr)
Exertional chest pain
Presyncope/syncope
Dyspnea
1
II
11I
Table 2. Comparison of Clinical Features in 8\ Patients With Age-
Predicted V02 max ::;70% Versus>70%
*p = 0.005 for dyspnea 1 versus dyspnea II and 11I (New York Heart
Association functional class); Dx =diagnosis. Other abbreviations as in Table 1.
Figure 2. The distribution of maximal oxygen consumption (V02
max) and percent of age/gender-predicted maximal oxygen con-
sumption (% V02 max). Percent of predicted V02 max was calcu-
lated with use of formulas: actual V02 max/60 - (0.55 x age) in
men; actual V02 max/48 - (0,37 x age) in women. pts = patients.
achieved ::::;70% of their age-predicted VOz max. In patients
whose VOz max was ::::;70% of the age-predicted maximum.
peak ejection and filling rates were reduced, the ratio of peak
filling rate to peak ejection rate was reduced, the ratio of
peak ejection rate to peak filling rate was increased and times
to peak ejection rate and to end-systole were prolonged.
Peak filling rate and time to end-systole were weakly related
to percent of predicted VOzmax achieved (r = 0.27, p < 0.05
and r = -0.28. p < 0.05. respectively). Left ventricular
cavity and left atrial dimensions. maximal left ventricular
wall thickness and other indexes of systolic and diastolic
function were similar in both groups.
Stepwise discriminant analysis was performed with six
measurements of cardiac structure and function that had a
probability value of <0.1 on univariate analysis: peak ejec-
tion rate. ratio of peak ejection to peak filling rate, time to
peak ejection rate. time to end-systole. peak fil1ing rate and
ratio of peak filling to peak ejection rate. These variables
were available in all patients and no patient was excluded
from the multivariate analysis. Discriminant analysis re-
vealed that reduced peak filling rate and prolonged time to
end-systole were the best predictors (p = 0.004) of patients
pta pta
25 25
20 20
15 15
10 10
5 5
0 0
5 10 1520 25 30 35 40 45 50 55 20 30 40 50 60 70 80 90 100 110120
V02 max (ml/min/kg) %V02 max (%)
79 ± 16
159 ± 23*
12.3 ± 3.9t
7.5 ± 5.4
% VOz max >70
(n = 45)
9.7 ± 4
7.1 ± 3.3
77 ± 17
138 ± 31
VOz max 0:;70
(n = 36)
Results
Exercise testing with respiratory gas analysis (Table 1). All
patients performed maximal symptom-limited exercise and
achieved anaerobic metabolism. Values for VOz max ranged
from 13.9 to 49.3 (mean 25.4 ± 7.7) ml/min per kg. Ex-
pressed as a percent of the age- and gender-predicted max-
imum, VOz max ranged from 34% to 116% (mean 73 ± 18%).
This value was below the maximum predicted value in 75
patients (93%) and ::::;70% of the age-predicted maximum in
36 (44%). The distribution of VOz max and percent of
age-predicted VOz max are shown in Figure 2. Peak heart
rate and exercise duration were greater in patients who
achieved >70% of their age-predicted VOzmax; heart rate at
rest and the rate of change in heart rate during exercise were
similar in the two groups (Table 1).
Relation of clinical features to exercise performance (Table
2). Clinical and echocardiographic findings in patients
whose VOz max was ::::;70% were compared with those in
patients whose VOz max was >70% of the age-predicted
maximum. Reduced exercise capacity was related to in-
creased symptoms (dyspnea grade II or III), p = 0.005, but
not to age or incidence of chest pain. presyncope and
syncope (Table 2).
Relation of exercise capacity to cardiac structure and
function in patients without a left ventricular outflow tract
gradient (Table 3). Fifty-nine patients did not have a rest left
ventricular outflow tract gradient; 34 achieved>70% and 25
Rest heart rate (beats/min)
Heart rate at peak exercise
(beats/min)
Exercise duration (min)
Slope of heart rate increase
(beats/minz)
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Table 3. Relation of Exercise Capacity to Cardiac Structure and
Function in 59 Patients Without a Left Ventricular Outflow
Tract Gradient
Table 4. Relation of Exercise Capacity to Cardiac Structure
and Function in 22 Patients With a Left Ventricular Outflow
Tract Gradient
%V02 max ::;;70
(n = 25)
% V02 max >70
(n = 34)
% V02 max ::;;70
(n = II)
% V02 max >70
(n = II)
*p = 0.07; tp = 0.06; tp = 0.007; §p = 0.005. AC = atrial contribution;
edv = end·diastolic volume; EF = ejection fraction; IVRP = isovolumetric
relaxation period; LA = left atrial; LV = left ventricular; PER = peak
ejection rate; % V02 max = percent of age·predicted maximal oxygen
consumption; PFR = peak filling rate; RFVI = relative filling volume by peak
filling rate; RFV2 = relative filling volume during the rapid filling period;
TES = time to end·systole; TPER = time to peak ejection rate; TPFR = time
to peak filling rate; V02 max = maximal oxygen consumption.
whose V02 max was ::;70% of their age-predicted maximum
(sensitivity 76%, specificity 62%).
Relation of exercise capacity to cardiac structure and
function in patients with left ventricular outflow tract gradient
(Table 4). Twenty-two patients had a calculated left ventric-
ular outflow tract gradient at rest >30 mm Hg; 11 of 36
achieved >70% and 11 of 45 achieved :s70% of their
age-predicted V02 max (p = NS). Patients whose V02 max
was ::;70% of the age predicted were younger (32 ± 12 vs. 40
± 20 years; p = NS) and had a longer duration of symptoms
before the study (9.1 ± 9.8 vs. 6.3 ± 6.3 years; p = NS). In
patients whose V02 max was :s70% of the age-predicted
maximum, peak ejection rate and ratio of peak ejection to
peak filling rate were reduced. The ratio of peak filling to
peak ejection rate and relative filling volume during the rapid
filling period were increased. Atrial contribution was de-
creased and the ratio of atrial contribution to left atrial
dimension was decreased. The ratios of peak ejection to
peak filling rate and of atrial systolic contribution to stroke
volume to left atrial dimension were related to percent of
predicted V02 max (r = 0.49, p = 0.02 and r = 0.54, p <
0.02, respectively). The magnitude of left ventricular outflow
tract gradient, left ventricular and atrial cavity dimensions,
maximal left ventricular wall thickness and other radionu-
elide indexes of systolic and diastolic function were similar
in both groups.
Stepwise discriminant analysis was performed with six
*p = 0.08; tp = 0.005; tp = 0.007; §p = 0.04; lip = 0.05; ~p = 0.008.
LVOT = left ventricular outflow tract; other abbreviations as in Table 3.
Discussion
Mechanism of symptoms. Dyspnea is a common symp-
tom in hypertrophic cardiomyopathy and frequently limits
exercise performance (1-4). The mechanisms of functional
limitation and particularly the relative importance of dias-
tolic impairment and a left ventricular outflow tract gradient
is difficult to ascertain. This difficulty has been complicated
by a reliance on reported symptoms rather than an objective
measurement of functional capacity. The development of
rapidly responding oxygen and carbon dioxide gas analyzers
has facilitated noninvasive, quantitative measurement of
respiratory gas exchange during exercise (5,6). We have
applied this method to 81 patients with hypertrophic cardio-
myopathy whose exercise capacity was limited by dyspnea
65 ± 19
26 ± 6
40 ± 4
24 ± 4
38 ± 8
79 ± 7
4.4 ± 0.7*
1.34 ± 0.24t
163 ± 18
368 ± 54
3.4 ± 0.9
0.77 ± o.m
192 ± 41
98 ± 37
40 ± 8
69 ± 9§
29 ± 911
0.79 ± o.m
58 ± 24
24 ± 5
40 ± 6
23 ± 3
43 ± 7
76 ± 9
3.8 ± 0.8
1.05 ± 0.18
181 ± 34
380 ± 59
3.7 ± I
0.98 ± 0.18
173 ± 53
95 ± 35
38 ± 12
78 ± 10
20 ± 10
0.47 ± 0.25
LVOT gradient (mm Hg)
Maximal LV wall thickness (mm)
LV end·diastolic dimension (mm)
LV end·systolic dimension (mm)
LA dimension (mm)
EF(%)
PER (edv/s)
PERlPFR
TPER (ms)
TES (ms)
PFR (edv/s)
PFRIPER
TPFR (ms)
IVRP (ms) (n = 21)
RFVI (%)
RFV2 (%) (n = 19)
AC (%) (n = 19)
AC/LA dimension (n = 19)
measurements of cardiac structure and function that had a
p value of < 0.1 on univariate analysis: peak ejection rate,
ratio of peak ejection to peak filling rate, ratio of peak filling
to peak ejection rate, relative filling volume during the rapid
filling period, atrial contribution and ratio of atrial systolic
contribution to stroke volume to left atrial dimension. Three
patients in whom atrial contribution could not be measured
were excluded from the analysis. Discriminant analysis
revealed that reduced ratio of peak ejection to peak filling
rate, reduced ratio of atrial contribution to left atrial dimen-
sion, reduced atrial contribution, increased relative filling
volume during the rapid filling period and increased ratio of
peak filling to peak ejection rate were the best predictors
(p = 0.0001) of patients whose V02 max was ::;70% of their
age-predicted maximum (sensitivity 90%, specificity 100%).
22 ± 5
44 ± 5
27 ± 5
38 ± 9
78 ± 8
4.2 ± 0.8*
1.2 ± 003*
177 ± 32t
352 ± 5U
3.7 ± I§
0.88 ± 0.2*
187 ± 40
120 ± 51
40 ± 12
77 ± 12
19 ± 12
0.52 ± OJ
22 ± 5
43 ± 6
27 ± 5
41 ± 8
75 ± II
3.8 ± 0.8
1.37 ± 0.4
193 ± 30
389 ± 47
2.9 ± 0.8
0.78 ± 0.2
189 ± 51
III ± 50
36 ± 10
76 ± II
19 ± 12
0.5 ± 0033
Maximal LV wall thickness (mm)
LV end-diastolic dimension (mm)
LV end·systolic dimension (mm)
LA dimension (mm)
EF(%)
PER (edv/s)
PERlPFR
TPER (ms)
TES (ms)
PFR (edv/s)
PFRIPER
TPFR (ms)
IVRP (ms) (n = 55)
RFVI (%)
RFV2 (%) (n = 56)
AC (%) (n = 56)
AC/LA dimension (n = 56)
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or fatigue, or both. Maximal oxygen consumption during
exercise was corrected for age and gender. The majority of
patients (93%) failed to achieve the age-predicted maximal
VOz and in 36 (44%) of these VOz max was :570% of the
predicted maximum. A VOz max :570% was considered to
best stratify patients with functional impairment (New York
Heart Association class II or greater) from those without
limitation (6). These findings are consistent with previous
reports of small numbers of patients with hypertrophic
cardiomyopathy (22).
Radionuclide indexes of left ventricular function. Exercise
capacity in hypertrophic cardiomyopathy is strongly related
to cardiac index (23). The influence ofheart rate on VOzmax
was also examined; the similarity of heart rate at rest and of
the slope of heart rate increase during exercise in patients
with and without marked functional limitation indicates that
impaired heart rate response to exercise was not the factor
responsible for exercise limitation in these patients. A small
proportion (-10%) of patients with hypertrophic cardiomy-
opathy experience progressive symptoms and exercise lim-
itation due to impaired systolic contractile performance
associated with left ventricular wall thinning and cavity
dilation (24). None of the patients in this study demonstrated
left ventricular wall thinning and cavity dilation and all had a
left ventricular ejection fraction 2::60%. A prolonged clinical
course also did not predict impaired exercise tolerance: age,
duration of symptoms and follow-up after diagnosis, as well
as the incidence and magnitude of a left ventricular outflow
tract gradient, were similar in both groups.
Previous reports have indicated that the left ventricular
ejection fraction decreases during exercise in the majority of
patients with hypertrophic cardiomyopathy, but it is unclear
whether this finding reflects a primary abnormality of con-
tractile performance or is secondary to diastolic dysfunction
(25,26). In the present study, radionuclide indexes of systolic
function were not assessed during exercise.
The assessment of diastolic function during exercise by
radionuclide indexes has been widely reported but there is
no consensus on which technique (equilibrium or first pass)
is optimal (26-28). Bonow et al. (29) reported that indexes of
left ventricular filling measured at rest may be more reliable
indicators of abnormalities in diastolic function than those
measured during exercise. The same group (30) demon-
strated that in patients with essential hypertension and left
ventricular hypertrophy the change in left ventricular ejec-
tion fraction during exercise was strongly correlated to the
peak filling rate measured at rest. Patients who were unable
to increase ejection fraction during exercise had low rest
peak filling rates; these authors (30) suggested that failure to
increase systolic performance during exercise was second-
ary to diastolic abnormalities. In a study of the effect of
verapamil in patients with hypertrophic cardiomyopathy,
Bonow et al. (31) demonstrated improved exercise duration
in association with increased peak filling rate measured at
rest. In our study peak filling rate at rest was significantly
related to the percent of age-predicted VOz max achieved
and was the strongest predictor of reduced exercise capacity
in patients without a left ventricular outflow tract gradient at
rest; this observation is consistent with the hypothesis that
exercise capacity is limited by diastolic functional impair-
ment.
Radionuclide indexes in relation to left ventricular outflow
tract gradient. Twenty-two patients had echocardiographic
evidence of a left ventricular outflow gradient at rest. Of
these, 20 did not achieve their age-predicted VOz max, and
in 11 the percent predicted VOz max was :570%. These 11
patients had reduced peak ejection rate and reduced atrial
contribution to stroke volume but were similar in age and
had values for left ventricular outflow tract gradient, maxi-
mal left ventricular wall thickness and other radionuclide
indexes that were similar to those of patients whose exercise
capacity was>70% of that predicted. Stepwise discriminant
analysis of radionuclide and echocardiographic indexes dem-
onstrated that reduced ratio of peak ejection to peak filling
rate and reduced atrial contribution to left atrial dimension
were the best predictors of patients with marked exercise
limitation (sensitivity 90%, specificity 100%). This observa-
tion suggests that impaired systolic function of both the left
atrium and the left ventricle were important determinants of
exercise limitation in these patients. Peak ejection rate is
more sensitive than ejection fraction in assessing systolic
function (32), but this index requires normalization to end-
diastolic volume in our method. In contrast, the ratio of peak
ejection to peak filling rate reflects the relation of left
ventricular ejection and filling rate that is independent of
end-diastolic volume and may be more sensitive than peak
ejection rate alone. Atrial contribution to stroke volume
divided by left atrial dimension is a ratio not previously
defined. This so-called atrial ratio reflects reduced atrial
systolic function in relation to increased left atrial cavity
dimension and may represent a point on the descending limb
of the atrial function curve. The atrial ratio was of greater
predictive value than was either atrial contribution or left
atrial dimension alone in patients with reduced exercise
capacity and a left ventricular outflow tract gradient at rest.
Conclusions. The predominant mechanisms of exercise
limitation in hypertrophic cardiomyopathy were different in
patients with and without a left ventricular outflow tract
gradient. The findings in hypertrophic cardiomyopathy with-
out a left ventricular outflow tract gradient were similar to
observations in patients with left ventricular hypertrophy
due to essential hypertension and indicated that exercise
limitation was related to diastolic dysfunction (30). The
mechanism of exercise limitation in patients with hyper-
trophic cardiomyopathy and a left ventricular outflow gradi-
ent at rest was related to impaired systolic performance of
both the left atrium and the left ventricle.
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